Newly spun out GE Healthcare Technologies Inc. presented preliminary results for the fourth quarter and full year 2022 at the 41st annual J.P. Morgan Healthcare Conference on Tuesday. The update followed the announcement of plans to purchase Imactis SAS, which developed CT-Navigation, a stereotactic needle guidance system. Terms of the Imactis deal were not disclosed.